T CELL LYMPHOBLASTIC LYMPHOMA
Clinical trials for T CELL LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T CELL LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T CELL LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target hard-to-treat t-cell cancers in early trial
Disease control Recruiting nowThis early-phase trial tests whether specially engineered immune cells (anti-CCR9 CAR T cells) made from a patient's own blood are safe and what dose works best. It includes children and adults with T-cell acute lymphoblastic leukemia or lymphoma that has come back or not respond…
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New trial aims to boost survival in kids with rare lymphoma
Disease control Recruiting nowThis study tests which of two chemotherapy methods works better for children newly diagnosed with T-cell lymphoblastic lymphoma, a rare cancer. About 200 children will receive either high-dose methotrexate or a different escalating dose, both combined with standard drugs. The goa…
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Promising drug cocktail targets tough blood cancers in kids
Disease control Recruiting nowThis study tests whether a combination of three drugs (calaspargase pegol-mknl, decitabine, and venetoclax) can help control relapsed or treatment-resistant T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LLy) in patients aged 1 month to 21 years.…
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:58 UTC